However, reduced synaptophysin has long been noted in aging and in a disease-specific, spatially-restricted manner in early stages of AD and some other neurodegeneration types (Masliah et al., 1989; Lippa, 2004; Martin et al., 2014). Here, SYP is linked to Alzheimer disease.